Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.4 million.
  • Biofrontera (NASDAQ:BFRA) shares rose 17.21% to $3.2. The market value of their outstanding shares is at $90.7 million.
  • Mainz Biomed (NASDAQ:MYNZ) stock moved upwards by 14.19% to $15.45. The company's market cap stands at $212.2 million.
  • Also check this: Tesla And 4 Other Stocks Sold By Insiders
  • Hims & Hers Health (NYSE:HIMS) shares rose 12.61% to $4.73. The company's market cap stands at $969.6 million. As per the press release, Q4 earnings came out yesterday.
  • NanoVibronix (NASDAQ:NAOV) shares increased by 11.18% to $0.83. The market value of their outstanding shares is at $23.1 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) shares rose 9.67% to $0.74. The market value of their outstanding shares is at $53.8 million.

 

Losers

  • Kodiak Sciences (NASDAQ:KOD) shares decreased by 72.4% to $13.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $718.8 million.
  • Ocugen (NASDAQ:OCGN) shares declined by 19.15% to $3.42. The company's market cap stands at $681.2 million.
  • Marinus Pharmaceuticals (NASDAQ:MRNS) shares declined by 10.56% to $10.0. The company's market cap stands at $367.6 million.
  • Plus Therapeutics (NASDAQ:PSTV) stock fell 9.61% to $0.91. The company's market cap stands at $19.3 million.
  • Diffusion Pharmaceuticals (NASDAQ:DFFN) stock declined by 8.71% to $0.21. The company's market cap stands at $21.9 million.
  • GreenLight Biosciences (NASDAQ:GRNA) shares fell 7.53% to $5.16. The market value of their outstanding shares is at $633.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.